Tetsuya Wakabayashi

6PUBLICATIONS
23CO-AUTHORS
AllergyMolecular targetsMedical molecular engineering of nucleic acids and proteinsIndustrial molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 22, 2023
Characterizations of a neutralizing antibody broadly reactive to multiple gluten peptide:HLA-DQ2.5 complexes in the context of celiac disease.

Yuu Okura, Yuri Ikawa-Teranishi, Akihiko Mizoroki

|Aug 28, 2020
Antibody to CD137 Activated by Extracellular Adenosine Triphosphate Is Tumor Selective and Broadly Effective In Vivo without Systemic Immune Activation.

Mika Kamata-Sakurai, Yoshinori Narita, Yuji Hori

|Jun 11, 2019
In vitro human helper T-cell assay to screen antibody drug candidates for immunogenicity.

Shunsuke Ito, Tatsuya Ikuno, Masayuki Mishima

|Mar 23, 2019
Controlled conductivity at low pH in Protein L chromatography enables separation of bispecific and other antibody formats by their binding valency.

Chen Chen, Tetsuya Wakabayashi, Masaru Muraoka

|Sep 11, 2018
MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicity.

Nobuo Sekiguchi, Chiyomi Kubo, Ayako Takahashi

|Oct 06, 2017
An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumors.

Takahiro Ishiguro, Yuji Sano, Shun-Ichiro Komatsu

Pageof 1

Frequent Collaborators

2 joint publications

Mika Kamata-Sakurai

2 joint publications

Tomoyuki Igawa

2 joint publications

Shunsuke Ito

2 joint publications

Yoshiki Kawabe